Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

GSK PLC Sponsored ADR (GSK) had Cash Flow from Financial Activities of $366.52M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$10.28B
Net Income	$2.34B
Cost of Goods Sold	$2.53B
Gross Profit	$7.75B
Operating Expenses	$7.19B
Operating Income	$3.09B
Non-Operating Income/Expense	$-200.78M
Pre-Tax Income	$2.89B
Normalized Pre-Tax Income	$2.89B
Income after Taxes	$2.48B
Income from Continuous Operations	$2.48B
Consolidated Net Income/Loss	$2.48B
Normalized Income after Taxes	$2.48B
EBIT	$3.09B
EBITDA	$3.71B
Weighted-Average Shares Outstanding (Basic)	2.01B
Weighted-Average Shares Outstanding (Diluted)	2.04B
Earnings per Share (EPS) (Basic)	$1.16
Earnings per Share (EPS) (Diluted)	$1.15
Balance Sheet Financials
Current Assets	$23.93B
Property, Plant, and Equipment	$12.59B
Long-Term Assets	$60.78B
Total Assets	$84.72B
Current Liabilities	$30.22B
Long-Term Debt	$18.88B
Long-Term Liabilities	$31.02B
Total Liabilities	$61.24B
Common Equity	$23.48B
Tangible Shareholders Equity	$-10.78B
Shareholders Equity	$23.48B
Common Shares Outstanding	2.01B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.54B
Cash Flow from Investing Activities	$-1.98B
Cash Flow from Financial Activities	$366.52M
Beginning Cash	$4.38B
End Cash	$4.31B
Increase/Decrease in Cash	$-68.72M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-866.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.79
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	1.09
Gross Margin	75.42%
Operating Margin	30.06%
EBIT Margin	30.06%
EBITDA Margin	--
Pre-Tax Profit Margin	28.10%
Profit Margin	22.77%
Free Cash Flow	$1.28B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.30
Receiveable Turnover	0.96
Days Sales in Receivables	93.63
Return on Equity	10.56%
Return on Tangible Equity	-22.98%
Return on Assets	2.93%
Return on Investments	5.85%
Book Value Per Share	$11.68
Free Cash Flow per Share	$0.63
Operating Cash Flow per Share	$0.75

Data from Zacks Investment Research, Inc.